Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Koren

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Leukemia|July 4, 2008
Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemiaA Shimoni, M Leiba, M Schleuning, et al.
European Heart Journal|December 3, 1999
Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled studyG Cotter, A Blatt, E Kaluski, et al.
Lancet (London, England)|March 3, 1998
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedemaG Cotter, E Metzkor, E Kaluski, et al.
Journal of the American College of Cardiology|September 19, 1998
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatinA S Brown, R G Bakker-Arkema, L Yellen, et al.
Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.
Leukemia|April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Leukemia|October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Leukemia|July 4, 2008
Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemiaA Shimoni, M Leiba, M Schleuning, et al.
European Heart Journal|December 3, 1999
Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled studyG Cotter, A Blatt, E Kaluski, et al.
Lancet (London, England)|March 3, 1998
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedemaG Cotter, E Metzkor, E Kaluski, et al.
Journal of the American College of Cardiology|September 19, 1998
Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatinA S Brown, R G Bakker-Arkema, L Yellen, et al.
Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.
Leukemia|April 12, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Leukemia|October 8, 2016
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemiaV Madan, P Shyamsunder, L Han, et al.
Pageof 3